SCHEMBL4892045

SCHEMBL4892045

[O]c1ccc([N+](=O)[O-])cn1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 4/20 0.50
ADRA2A P08913 2/20 0.50
ADRA2B P18089 2/20 0.50
ADRA2C P18825 2/20 0.50
SLC2A1 P11166 1/20 0.50
LMNA P02545 4/20 0.49
KMT2A Q03164 4/20 0.49
ALDH1A1 P00352 3/20 0.49
MEN1 O00255 2/20 0.49
CYP1A2 P05177 2/20 0.49
ALOX12 P18054 2/20 0.49
GAA P10253 1/20 0.49
NPSR1 Q6W5P4 1/20 0.49
TDP1 Q9NUW8 1/20 0.47
KDM4E B2RXH2 1/20 0.47
AGTR1 P30556 1/20 0.47
HSPB1 P04792 1/20 0.46
CYP2C9 P11712 1/20 0.46
HPGD P15428 1/20 0.46
HSP90AA1 P07900 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3156019 0.79 MAPT (0.52) MAPTADRA2AADRA2BADRA2CSLC2A1
SCHEMBL29580092 0.77 MAPT (0.50) MAPTADRA2AADRA2BADRA2CSLC2A1
SCHEMBL10936934 0.77 MAPT (0.50) MAPTADRA2AADRA2BADRA2CSLC2A1
SCHEMBL202616 0.77 ADRA2A (0.55) MAPTADRA2AADRA2BADRA2CSLC2A1
SCHEMBL14450630 0.76 MAPT (0.49) MAPTADRA2AADRA2BADRA2CSLC2A1
SCHEMBL180816 0.76 MAPT (0.49) MAPTADRA2AADRA2BADRA2CSLC2A1
SCHEMBL295867 0.76 SLC2A1 (0.53) MAPTADRA2AADRA2BADRA2CSLC2A1
SCHEMBL5473 0.76 KMT2A (0.50) MAPTADRA2AADRA2BADRA2CSLC2A1
SCHEMBL18403105 0.76 MAPT (0.49) MAPTADRA2AADRA2BADRA2CSLC2A1
SCHEMBL16289876 0.76 MAPT (0.49) MAPTADRA2AADRA2BADRA2CSLC2A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 44 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9580444-B2 Polycyclic pyrazolinone derivative and herbicide comprising same as effective component thereof SAGAMI CHEMICAL RESEARCH INSTITUTE (JP) 2017-02-28 US disclosed
US-20160024110-A1 POLYCYCLIC PYRAZOLINONE DERIVATIVE AND HERBICIDE COMPRISING SAME AS EFFECTIVE COMPONENT THEREOF KAKEN PHARMACEUTICAL CO., LTD. (JP) 2016-01-28 US disclosed
EP-2975040-A1 POLYCYCLIC PYRAZOLINONE DERIVATIVE AND HERBICIDE COMPRISING SAME AS EFFECTIVE COMPONENT THEREOF Sagami Chemical Research Institute (JP) 2016-01-20 EP disclosed
US-7425568-B2 Compounds, which are potent inhibitors of Na+ /Ca2+ exchange mechanism and are useful in the treatment of arrhythmias ORION CORPORATION (FI) 2008-09-16 US disclosed
US-20080063977-A1 Method of increasing speed of silver halide color photosensitive material FUJIFILM CORPORATION 2008-03-13 US disclosed
US-7153638-B2 Silver halide color photosensitive material FUJI PHOTO FILM CO., LTD. (JP) 2006-12-26 US disclosed
US-7115356-B2 Extremely high image quality excelling in graininess and in bright acuity; 5-membered azole ring containing 2 to 4 nitrogen atoms; a a heterocyclic ring having one or two heteroatoms including the nitrogen atom; red, green and blue sensitive FUJI PHOTO FILM CO., LTD. (JP) 2006-10-03 US disclosed
EP-1412343-B1 COMPOUNDS, WHICH ARE POTENT INHIBITORS OF NA+/CA2+ EXCHANGE MECHANISM AND ARE USEFUL IN THE TREATMENT OF ARRHYTHMIAS ORION CORP (FI) 2006-08-30 EP disclosed
US-7074550-B2 Silver halide color photosensitive material FUJI PHOTO FILM CO., LTD. (JP) 2006-07-11 US disclosed
EP-1041438-B1 Silver halide photographic light-sensitive material, heterocyclic azo dye forming compound, and method of preparing dye FUJI PHOTO FILM CO LTD (JP) 2006-06-14 EP disclosed
US-20030175627-A1 Method of increasing speed of silver halide color photosensitive material FUJI PHOTO FILM CO., LTD. 2003-09-18 US disclosed
CN-1115334-C Pyridine derivative and medicine containing the same OTSUKA PHARMA CO LTD (JP) 2003-07-23 CN disclosed
US-6518006-B2 Yellow-developing photosensitive silver halide emulsion layer on a support contains one dye-forming coupler, and nonphotosensitive hydrophilic colloid layers contain dispersion of dye; sharpness, high strength FUJI PHOTO FILM CO., LTD. (JP) 2003-02-11 US disclosed
WO-2003006452-A1 NEW COMPOUNDS, WHICH ARE POTENT INHIBITORS OF NA+/CA2+ EXCHANGE MECHANISM AND ARE USEFUL IN THE TREATMENT OF ARRHYTHMIAS ORION CORPORATION (FI) 2003-01-23 WO disclosed
US-20020048733-A1 Silver Halide color photographic photosensitive material FUJIFILM CORPORATION (JP) 2002-04-25 US disclosed
EP-0831368-B1 Silver halide color photographic light-sensitive material FUJI PHOTO FILM CO LTD (JP) 2001-06-20 EP disclosed
US-6200742-B1 EXCELLENT COLOR REPRODUCIBILITY, SHARPNESS AND COLORFASTNESS BY INCLUDING IN THE LIGHT SENSITIVE MATERIAL A COUPLER (A FUSED 1,2,4-OXADIAZOLE RING) THAT PROVIDES AN AZO DYE HAVING EXCELLENT HUES, LARGE MOLAR EXTINCTION COEFFICIENT; STABILITY FUJI PHOTO FILM CO., LTD. (JP) 2001-03-13 US disclosed
EP-1041438-A1 Silver halide photographic light-sensitive material, heterocyclic azo dye forming compound, and method of preparing dye FUJI PHOTO FILM CO., LTD. (JP) 2000-10-04 EP disclosed
US-5948607-A DYE FORMING COUPLER; EXCELLENT IN COLOR REPRODUCIBILITY, SHARPNESS AND COLOR IMAGE FASTNESS. FUJI PHOTO FILM CO., LTD. (JP) 1999-09-07 US disclosed
EP-0831368-A1 Silver halide color photographic light-sensitive material FUJI PHOTO FILM CO., LTD. (JP) 1998-03-25 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20160024110-A1 POLYCYCLIC PYRAZOLINONE DERIVATIVE AND HERBICIDE COMPRISING SAME AS EFFECTIVE COMPONENT THEREOF DDT, PDHX, CYP4X1 MAPT 4308/4885ADRA2A 3534/4885ADRA2B 3264/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.